Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
DUSA Pharmaceuticals, Inc. is an integrated dermatology specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform, and complementary dermatology products. Levulan PDT is currently approved for the treatment of pre-cancerous actinic keratoses, and is being developed for the treatment of acne. DUSA’s other dermatology products include Nicomide®, and the AVAR® line. These products target patients with acne and rosacea. DUSA is also developing certain internal indications of Levulan PDT. DUSA is based in Wilmington, MA. ( www.dusapharma.com )
DUSA Pharmaceuticals , Inc.
25 Upton Dr.
Wilmington, Massachusetts 01887
USA
Tel: (978) 657-7500
Fax: (978) 657-9193